Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers: A Randomized, Open-Label, Two-Period, Parallel-Group, Crossover Study

Author: Nichols Alice I.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.31, Iss.3, 2011-03, pp. : 155-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content